Displaying 731 - 740 of 1671
Report
04.02.2019
Families USA filed an amicus brief in the Texas v. US case that threatens the entire Affordable Care Act, on appeal in the US Court of Appeals of the Fifth Circuit. Cosigners of the amicus include…
Fact Sheet
04.02.2019
Kansas lawmakers are currently considering legislation that could expand Medicaid to 150,000 nonelderly, low-income Kansans. As lawmakers debate Medicaid expansion in the state’s legislature, Families USA has published a fact sheet on the impact…
Report
03.31.2019
On May 16th, the Centers for Medicare and Medicaid Services announced a final regulation for Medicare’s Part D drug benefit for 2020. The regulation backed off of a proposal that would have created significant exceptions to…
Webinar
03.28.2019
Federal Judge Boasberg struck down work requirements for the Medicaid program in both Arkansas and Kentucky. This March 28th webinar discussed the Judge's ruling and what it means for the future of Medicaid. Featured…
Report
03.26.2019
Key findings On March 26, 2019, the chairs of three House committees with jurisdiction over core health care issues—Education and Labor, Energy and Commerce, and Ways and Means—jointly introduced legislation that would lower health…
Fact Sheet
03.26.2019
Oral health is an important aspect of overall health and influences physical and mental well-being, but receives less of its fair share of attention and resources. For people with mental health conditions and substance…
Insights Column
03.25.2019
State health plans for families are under scrutiny – in the courts, in the states, and in Washington. It is hard to think of a time when the Medicaid program was getting so much…
Webinar
03.25.2019
From Trump administration block grant proposals, to work requirements in the federal courts, to the waiver restrictions faced in the Capitol hallways of West Virginia; Medicaid waivers are under scrutiny. Speakers examine what's happening…
Report
03.21.2019
Eight in ten Americans say the cost of prescription drugs is “unreasonable.” This is a problem driven by high launch prices and price increases, which are rooted in drug corporations’ monopoly power and perverse incentives…
Social Toolkit
03.21.2019